CLD-101 is a novel stem cell-based treatment that delivers oncolytic viruses to tumors, which may benefit patients with newly ...

Briquilimab was well tolerated in the study. No SAEs or AEs grade 3 were reported. Furthermore, there were no reported AEs related to hair or skin color changes, hypersensitivity, or anemia. Mild ...

HBI0101, an academically sourced CAR T-cell therapy, demonstrated a high objective response rate and manageable safety in ...

No serious adverse events; no grade 3 or higher adverse events reported Initial data from BEACON study expected week of January 6 th, 2025, including 180mg Q8W cohort Company to host conference call ...

Trial will evaluate multiple doses of CLD-101 for the treatment of newly diagnosed high-grade gliomaCLD-101 is Calidi’s novel allogeneic ...

When Paul Fleischman was 19, the Monterey-born, Santa Monica-raised teen decided he was ready to see another part of the ...

An investigational oral antiviral drug eased bronchiolitis and was safe for children 2 years and younger hospitalized with ...

After a one-year hiatus and two years of COVID-reduced programming, the Decatur Book Festival made its comeback this weekend, welcoming a wide range of local, national and emerging authors, ...

Gender biases around male and female roles and under-representation of female characters appeared in textbooks from around the world, with male-coded ...

Studying 35 participants, the results showed that all devices accurately detected sleeping and wakeful states. However, the ...

The S4 candidates will be briefed on October 11 and sit for their first paper in on October 14 under the new lower secondary ...